MEM 11.1% 0.8¢ memphasys limited.

Ann: Memphasys & Monash IVF commence clinical trial of FELIX, page-13

  1. 44 Posts.
    lightbulb Created with Sketch. 9
    did you even read it?

    “The study is an important milestone on the path to securing regulatory approval in Australia
    and, subsequently, in key markets such as the USA. We have already sold a Felix™ System
    to a Chinese KOL site for research purposes and this trial should accelerate interest in further
    research sales in the future. It will also supplement the current commercialisation of the Felix™
    System in markets with lower regulatory hurdles where sales can occur now, such as Japan,
    India, Canada, New Zealand” she added.

    Commercial discussions are well underway with IVF centres in these four markets, with the
    Company looking to secure at least one commercial sale in this calendar year from a clinic
    operating within one of these jurisdictions

 
watchlist Created with Sketch. Add MEM (ASX) to my watchlist
(20min delay)
Last
0.8¢
Change
-0.001(11.1%)
Mkt cap ! $11.06M
Open High Low Value Volume
0.8¢ 0.8¢ 0.8¢ $1.2K 150K

Buyers (Bids)

No. Vol. Price($)
4 1024718 0.8¢
 

Sellers (Offers)

Price($) Vol. No.
0.9¢ 751162 2
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
MEM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.